Brief: Sundial And Crescita Sign Exclusive Partnership To Develop Cannabis And Hemp Topicals

Crescita Therapeutics

28/10/2019 11:55

Oct 28 (Reuters) - Crescita Therapeutics Inc  CTX.TO :
    * SUNDIAL AND CRESCITA SIGN EXCLUSIVE PARTNERSHIP TO DEVELOP
CANNABIS AND HEMP TOPICALS
    * CRESCITA THERAPEUTICS - DEVELOPMENT & LICENSING AGREEMENT
GRANTING SUNDIAL WORLDWIDE RIGHTS TO CO'S PROPRIETARY
TRANSDERMAL DELIVERY TECHNOLOGIES
    * CRESCITA THERAPEUTICS- SUNDIAL WILL FUND DEVELOPMENT &
FORMULATION COSTS,WILL HAVE WORLDWIDE MARKETING & DISTRIBUTION
RIGHTS FOR NEW PRODUCTS
    * CRESCITA THERAPEUTICS- SUNDIAL WILL SUPPORT CO IN APPLYING
FOR
AND OBTAINING HEALTH CANADA STANDARD PROCESSING LICENSE FOR
CANNABIS
    * CRESCITA THERAPEUTICS INC - CBD-INFUSED ROLL-ON AND
TOPICAL
CREAM ARE EXPECTED TO BE AVAILABLE FOR PURCHASE IN EARLY 2020

Source text for Eikon:  ID:nPn6xh5Yza 
Further company coverage:  CTX.TO 

 ((Reuters.Briefs@thomsonreuters.com;))